Leave message
Can’t find what you’re looking for?
Fill out this form to inquire about our custom protein services!
Inquire about our Custom Services >>
Cat. No. | Species | Product Description | Structure | Purity | Feature |
---|---|---|---|---|---|
FABm021-01 | Mouse | PE-Labeled Monoclonal Anti-Human CD45RO Antibody, Mouse IgG2a (UCHL1) (0.03% Proclin) |
![]() ![]() |
||
CDO-H52H3 | Human | Human CD45RO Protein, His Tag (MALS verified) | ![]() |
![]() ![]() |
|
HGS-S249 | Mouse | Recombinant Monoclonal Anti-CD45RO Antibody, Mouse (4C8) |
Flow cytometric analysis of Jurkat staining with PE-Labeled Monoclonal Anti-Human CD45RO Antibody, Mouse IgG2a (UCHL1) (Cat. No. FABm021-01) at 1:20 dilution (5 μL of the antibody stock solution corresponds to labeling of 1e6 cells in a final volume of 100 µL), compared with isotype control antibody. PE signal was used to evaluate the binding activity (QC tested).
The purity of Human CD45RO Protein, His Tag (Cat. No. CDO-H52H3) is more than 85% and the molecular weight of this protein is around 80-105 kDa verified by SEC-MALS.
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
Immunomodulatory progenitor cell therapy (Celixir) | Phase 3 Clinical | Celixir | Endomyocardial Fibrosis; Cardiomyopathies | Details | |
I-131-Apamistamab | BC8-I-131; BC-8; 131IBC8 | Phase 3 Clinical | Fred Hutchinson Cancer Research Center | Neoplasms, Gonadal Tissue; Lymphoma, Mantle-Cell; Sezary Syndrome; Lymphoma, Non-Hodgkin; Leukemia, Myeloid, Acute; Lymphoma; Burkitt Lymphoma; Intraocular Lymphoma; Lymphoma, T-Cell; Lymphoma, Follicular; Waldenstrom Macroglobulinemia; Lymphoma, Large-Cell, Anaplastic; Lymphoma, T-Cell, Cutaneous; Anemia, Sideroblastic; Angioimmunoblastic T-cell Lymphoma; Leukemia, Large Granular Lymphocytic; Leukemia, Lymphocytic, Chronic, B-Cell; Mycosis Fungoides; Leukemia-Lymphoma, Adult T-Cell; Leukemia; Lymphoma, B-Cell, Marginal Zone; Lymphoma, T-Cell, Peripheral; Hematopoietic stem cell transplantation (HSCT); Neoplastic Cells, Circulating; Leukemia, Hairy Cell; Anemia, Refractory, with Excess of Blasts; Lymphoma, Large B-Cell, Diffuse; Lymphoma, B-Cell; Myelodysplastic Syndromes; Leukemia, Myelomonocytic, Chronic; Hodgkin Disease; Lymphoma, Large-Cell, Immunoblastic; Lymphomatoid Granulomatosis; Lymphoma, Extranodal NK-T-Cell; Pancytopenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma | Details |
At 211 MAb BC8-B10 | Phase 2 Clinical | Fred Hutchinson Cancer Research Center | Neoplasms | Details |
This web search service is supported by Google Inc.